Diagnostics

Whereas affordable HCV self-testing can improve HCV screening, the price and availability of virologic testing, required to confirm HCV diagnosis prior to treatment, remains a major obstacle to HCV elimination in LMICs and must be urgently addressed. More

A study assessed the usability and acceptability of HCV antibody self-testing in a high HCV prevalence informal settlement in Karachi, Pakistan. More

An article explores a hepatitis C testing program implemented at a remand prison, highlighting the role of oral swabs and peer involvement in increasing testing rates. More

The purpose of the guide is to support countries in developing policies that define a strategic mix of hepatitis B and C testing approaches, tailored to their unique situation ensuring an impactful national response to the hepatitis epidemic. More

The study found 1.4 million people aged 12-59 with current HCV infection, including over 500,000 without injection drug use history. More

Findings support the feasibility and clinical performance of Xpert HCV, the first FDA-approved point-of-care test for diagnosing HCV, in a nonclinical justice setting. More

Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers More

Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population More

Community-based HCV self-testing could broaden access to testing by reaching previously untested people, could boost new HCV diagnoses and expand linkage to HCV care. More

Among patients in 3 priority settings, the implementation of hepatitis C virus antibody and RNA point-of-care testing led to higher rates of testing, treatment uptake, and linkage to care. More